ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 068

Identification of Challenges in the Quality of Referrals to a Pediatric Rheumatology Center: A Retrospective Chart Review

Ritika Patel1, Elizabeth Hussar2, Amira Elfergani2, Freddy Murgida2, Alexandra Sutherland3 and Barbara Ostrov4, 1Albany Medical College, Albany, NY, 2Albany Medical Center, 3Albany Medical Center, Albany, NY, 4Albany Medical College, Slingerlands, NY

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Quality, Health Services, and Education Research I

Session Time: 6:00PM-7:00PM

Background/Purpose: Recently, there has been an increase in referrals to Pediatric Rheumatology (PR) for non-specific symptoms and test results rather than clearcut inflammatory and/or autoimmune disease. This increases time spent on non-rheumatologic conditions by the already limited number of PRs. There are approximately 450 PR in the US; a 16% decrease in workforce by 2030 is predicted. This will not be an adequate number of PR to give sufficient care to the number of children referred. Referrals to PR often lack essential information, leading to delayed evaluations, unnecessary testing, and increased healthcare utilization. High quality referral documentation is crucial to expedite care and optimize outcomes. This study aims to evaluate quality and completeness of referrals to our PR center from 2021 to 2023. 

Methods: A retrospective chart review was conducted of all new patient referrals from 2021 to 2023. Referrals were assessed for completeness and quality of key elements and proposed diagnoses. Quality was assessed on five factors (clarity, appropriateness, clinical history, physical exam (PE), and testing) using descriptive criteria and qualitative scoring: good, fair, or poor. Associations between referral quality, provider specialty and training, and ultimate diagnoses were analyzed using descriptive statistics and Chi-square tests. IRB approval was obtained.

Results:
A total of 1345 charts were identified.  257 charts were excluded mainly due to duplications (7), no referral (154), internal referral (48), and previous diagnoses (39). Of the 1088 charts included, 52% scored “poor” in at least one domain; 18.38%, 23.71% and 28.95% scored “poor” in documentation of clinical history, PE, or inclusion of relevant test results, respectively.  

In the total population, compared to advanced practice providers (APP), physicians were statistically significantly more likely to have referral clarity rated ‘good’ (χ²= 6.8644, p< 0.05).  Among the two most common referring specialties, pediatrics (n=802) and family medicine (n=117), there were no significant differences in referral quality – nor between APPs and physicians within either specialty. However, of the pediatric and family medicine referrals, 53% and 48%, respectively, scored “poor” in at least one domain.  Rheumatologic diagnoses were ultimately made in 40% of all referrals.  These charts were more likely to be scored ‘good’ for appropriateness of the referral (χ²= 26.3724, p< 0.00001). 

Conclusion: Referral quality to PR is highly variable, with frequent omission of essential details and poor quality among key elements. Referrals leading to non-rheumatologic diagnoses take time away from evaluation of patients with rheumatic diagnoses from the limited number of PR.  Standardized referral templates and provider education, especially regarding clarity of diagnostic concerns, may improve the quality of referrals and streamline specialty care delivery.   


Disclosures: R. Patel: None; E. Hussar: None; A. Elfergani: None; F. Murgida: None; A. Sutherland: None; B. Ostrov: None.

To cite this abstract in AMA style:

Patel R, Hussar E, Elfergani A, Murgida F, Sutherland A, Ostrov B. Identification of Challenges in the Quality of Referrals to a Pediatric Rheumatology Center: A Retrospective Chart Review [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/identification-of-challenges-in-the-quality-of-referrals-to-a-pediatric-rheumatology-center-a-retrospective-chart-review/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-challenges-in-the-quality-of-referrals-to-a-pediatric-rheumatology-center-a-retrospective-chart-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology